⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TLX News
Telix Pharmaceuticals Limited American Depositary Shares
TLX LAWSUIT ALERT: Levi & Korsinsky Notifies Telix Pharmaceuticals Ltd. Investors - Lead Plaintiff Deadline January 9, 2026
accessnewswire.com
TLX
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
TLX
Levi & Korsinsky Reminds Telix Pharmaceuticals Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 - TLX
prnewswire.com
TLX
TLX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Telix Pharmaceuticals Limited Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
TLX
Pomerantz LLP Informs Shareholders of Securities Class Action Against Telix Pharmaceuticals Limited – TLX
accessnewswire.com
TLX
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Ltd. Securities Fraud Lawsuit Filed by The Rosen Law Firm
prnewswire.com
TLX
Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately
prnewswire.com
TLX
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals
newsfilecorp.com
TLX
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX
globenewswire.com
TLX
Levi & Korsinsky Urges Telix Pharmaceuticals Ltd. (TLX) Shareholders to Act Before Lead Plaintiff Deadline January 9, 2026
accessnewswire.com
TLX